DECRO Jacketed Telemetry Solution Brochure 2025 EN
4Pages

JACKETED TELEMETRY SOLUTION FOR ECG, RESPIRATORY ENDPOINTS, AND ACTIVITY MONITORING — Simple and reliable recording for short-term and longitudinal studies — Designed for freely moving, single or group-housed, small to large animals — Data analysis software with automatic analysis of physiological parameters — 3Rs impact: reduce and refine your in-vivo studies

Data view and analysis in a web browser, without any installation DIRECT ETHERNET OR LOCAL NETWORK »» A range of easy-to-set-up solutions, scalable to your needs (record 1 to 8+ animals simultaneously): • DECRO Nano (cloud-based analysis), Start, or Advanced. • Soft, stretch and resistant Embeds plethysmographic sensors • Protects the 2 external ECG electrodes » Available in different sizes and for different species COMPONENTS OF THE SOLUTION The emitter • Physiological signals transmission via Bluetooth low-energy • x2 battery packs rechargeable on USB • Optimized ergonomics to allow the...

ALL-IN-ONE SOLUTION FOR RAPID AND RELIABLE RESULTSAVAILABLE *PARAMETERS External ECG • Q-Tic (7 correction fomulas) (ms) Respiratory Inductive Plethysmography • Automatic detection of respiratory cycle • Respiratory cycle time (ms) • Respiratory rate (brpm) • Inspiratory-Expiratory time (sec) and ratio • Minute volume (Ua/min or mL/min) • PIF/PEF (Ua/sec or mL/sec) Triaxial accelerometer • Overall Dynamic Body Acceleration (ODBA) (mG) • Activity index (normalized 3D acceleration in mG every second) • Behaviour (spontaneous activity, chronobiology) » ket well accepted by socially-housed...

APPLICATIONS» PHARMACOLOGYAND SAFETY-TOXICOLOGY,GLP OR NON GLP • Available for dogs, minipigs (adult and juvenile13), marmosets and rats to cover the most commonly used species in these study types • Pharmacological effects of small molecules, biological compounds4-5-10, or active metabolites with extended kinetics • Combined safety-pharmacology and toxicology studies5,7 • Evaluation of QT interval variations* • Internal data » PHENOTYPING OF DISEASE MODELS • Cardiac8,12, respiratory, neurological, and metabolic effects (e.g., diabetes, obesity) • Fragile models that do not tolerate...